Compound Detail
CHEMBL30752
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL30752 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | VUOSBBZWOPIIAE-BQYQJAHWSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
343.3
MW (Da)
4.30
ALogP
2
HBA
1
HBD
38.3
PSA (Ų)
0.66
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 6.82
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Human immunodeficiency virus type 1 reverse transcriptase CHEMBL247 | IC50 | 6.82 | 6.82 | 151.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Human immunodeficiency virus type 1 reverse transcriptase | IC50 | = | 151.0 | nM | 6.82 | Compound was evaluated for its ability to inhibit HIV-1 Reverse Transcriptase in... | 11378361 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 11378361 | 10.1016/s0960-894x(01)00239-6 | Human immunodeficiency virus type 1 reverse transcriptase | 3 |
Data from ChEMBL 36 via Core Engine